We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center.
- Authors
Wang, Zuopeng; Zhao, Xiaolong; Li, Kai; Yao, Wei; Dong, Kuiran; Xiao, Xianmin; Zheng, Shan
- Abstract
<bold>Purpose: </bold>Inflammatory myofibroblastic tumor (IMT) is a rare benign neoplasm. The purpose of this study was to review the clinical characteristics, imaging and pathological features, and outcomes of children with IMTs from a single center in China.<bold>Methods: </bold>A retrospective file review was conducted involving 23 cases of pathologically confirmed IMTs treated at the Children's Hospital between April 2003 and April 2014.<bold>Results: </bold>The tumor locations included multiple anatomic sites, as follows: abdomen or pelvis (n = 17); lungs (n = 2); head and neck (n = 1); trunk (n = 1); and extremities (n = 2). The tumors were associated with various clinical presentations. The predominant symptoms included an anemic appearance, fevers, and an asymptomatic mass. Computed tomography scanning showed solid, heterogeneous, well-demarcated masses; the appearance of enhancement was variable. MRI appeared hypointense on T1-weighted images and hypointense or hyperintense on T2-weighted images. Immunohistochemical staining revealed anaplastic lymphoma kinase was negative in 11 of 13 cases tested. One patient quit treatment for the unresectable mass after biopsy and died 2 years later, and another patient with incompletely resection is alive at 30 months following chemotherapy. The remaining 21 cases had complete resections; one patient died due to a recurrence, and the other 20 patients survived and were tumor free. The follow-up ranged from 7 to 141 months, with a mean of 56 months. The 3-year OS was 88 % (95 % CI, 57-97 %).<bold>Conclusions: </bold>IMT is a benign neoplasm that rarely presents with malignant features. Complete resection is curative in most patients. ALK+ is variable for diagnosis. Close follow-up is necessary for patients who undergo surgical resection.
- Subjects
CHINA; INFLAMMATION; MYOFIBROBLASTS; RARE diseases; HEALTH outcome assessment; RETROSPECTIVE studies; COMPARATIVE studies; COMPUTED tomography; LONGITUDINAL method; MAGNETIC resonance imaging; RESEARCH methodology; MEDICAL cooperation; RESEARCH; EVALUATION research; CONNECTIVE tissue tumors; TUMOR treatment
- Publication
Pediatric Surgery International, 2016, Vol 32, Issue 3, p239
- ISSN
0179-0358
- Publication type
journal article
- DOI
10.1007/s00383-015-3840-7